4//SEC Filing
Cawkwell Gail 4
Accession 0001209191-23-006982
CIK 0001557746other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 4:58 PM ET
Size
8.1 KB
Accession
0001209191-23-006982
Insider Transaction Report
Form 4
Cawkwell Gail
Chief Medical Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2023-02-01+105,000→ 105,000 totalExercise: $16.97Exp: 2033-01-31→ Common Stock (105,000 underlying) - Award
Restricted Stock Units
2023-02-01+30,000→ 30,000 total→ Common Stock (30,000 underlying)
Footnotes (3)
- [F1]Exercisable with respect to 25% of the shares subject to the option vesting in four equal installments on the first, second, third and fourth anniversaries of February 1, 2023, subject to the Continuous Service of the Reporting Person (as defined in the Plan) as of each such date.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
- [F3]The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 1, 2023, subject to the Continuous Service of the Reporting Person (as defined in the Plan) as of each such date.
Documents
Issuer
Aclaris Therapeutics, Inc.
CIK 0001557746
Entity typeother
Related Parties
1- filerCIK 0001761167
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 4:58 PM ET
- Size
- 8.1 KB